A novel facet to consider for the effects of butyrate on its target cells. Focus on "The short-chain fatty acid butyrate is a substrate of breast cancer resistance protein"
- PMID: 21832244
- PMCID: PMC3213925
- DOI: 10.1152/ajpcell.00290.2011
A novel facet to consider for the effects of butyrate on its target cells. Focus on "The short-chain fatty acid butyrate is a substrate of breast cancer resistance protein"
Figures
Comment on
-
The short-chain fatty acid butyrate is a substrate of breast cancer resistance protein.Am J Physiol Cell Physiol. 2011 Nov;301(5):C984-94. doi: 10.1152/ajpcell.00146.2011. Epub 2011 Jul 20. Am J Physiol Cell Physiol. 2011. PMID: 21775706
References
-
- Alrawi SJ, Schiff M, Carroll RE, Dayton M, Gibbs JF, Kulavlat M, Tan D, Berman K, Stoler DL, Anderson GR. Aberrant crypt foci. Anticancer Res 26: 107–119, 2006 - PubMed
-
- Anna Rawluszko A, Krokowicz P, Jagodzinski PP. Butyrate induces expression of 17beta-hydroxysteroid dehydrogenase type 1 in HT29 and SW707 colorectal cancer cells. DNA Cell Biol. In press - PubMed
-
- Borthakur A, Gill RK, Hodges K, Ramaswamy K, Hecht G, Dudeja PK. Enteropathogenic Escherischia coli inhibits butyrate uptake by altering the apical membrane MCT1 level. Am J Physiol Gastrointest Liver Physiol 290: G30–G35, 2006 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
